leuprolide and Sarcoma

leuprolide has been researched along with Sarcoma* in 3 studies

Reviews

1 review(s) available for leuprolide and Sarcoma

ArticleYear
Myometrial and stromal lesions of the uterus.
    Clinics in laboratory medicine, 1995, Volume: 15, Issue:3

    This article is an overview of uterine neoplasms that demonstrate mesenchymal differentiation. Major clinical and pathologic features are described, with a focus on those lesions that cause diagnostic difficulty. Brief discussions on more recent observations made concerning these entities are also included.

    Topics: Adenofibroma; Adenomyoma; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Leiomyomatosis; Leuprolide; Myometrium; Receptors, Cell Surface; Sarcoma; Stromal Cells; Uterine Neoplasms; Uterus

1995

Other Studies

2 other study(ies) available for leuprolide and Sarcoma

ArticleYear
Effects of leuprolide acetate on low-grade endometrial stromal sarcoma.
    American journal of obstetrics and gynecology, 2000, Volume: 182, Issue:5

    We describe a low-grade endometrial stromal sarcoma coexistent with leiomyoma and adenomyosis treated with leuprolide acetate. We describe its histologic characteristics and clinical significance.

    Topics: Adult; Endometrial Neoplasms; Endometriosis; Female; Humans; Leiomyoma; Leuprolide; Neoplasms, Multiple Primary; Sarcoma

2000
Metastatic, sarcomatoid, and PSA- and PAP-negative prostatic carcinoma: diagnosis by fine-needle aspiration.
    Diagnostic cytopathology, 2000, Volume: 23, Issue:3

    Fine-needle aspiration of prostatic carcinoma usually yields an acinar carcinoma that is immunoreactive for prostatic-specific antigen (PSA) and prostatic acid phosphatase (PAP). We report on two FNAs of metastatic sarcomatoid prostatic carcinoma that were PSA- and PAP-negative. Our methods included a review of the medical records and pathology results. Both cases presented with elevated serum PSA levels and prostate needle biopsies with Gleason score 8 and 9 tumors, respectively. Both cases developed retroperitoneal/pelvic lymphadenopathy, and fine-needle aspirations were performed. These showed high-grade, sarcomatoid tumors with marked anisonucleosis. Immunocytochemical staining for PSA and PAP was negative in both cases. Clinical and radiologic evaluation failed to reveal any other potential primary sites. Metastatic, sarcomatoid, PSA- and PAP-negative prostatic carcinoma is a rare diagnosis of exclusion that should be considered in the characteristic clinical setting.

    Topics: Acid Phosphatase; Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoembryonic Antigen; Flutamide; Humans; Immunohistochemistry; Keratins; Leuprolide; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Sarcoma

2000